Detail akcie Accuray online

Business Summary: Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Financial Summary: BRIEF: For the fiscal year ended 30 June 2024, Accuray Inc revenues decreased less than 1% to $446.6M. Net loss increased 68% to $15.5M. Revenues reflect Product segment increase of less than 1% to $234.2M, China segment increase of 36% to $103.4M, Europe, Middle East, India and Africa segment increase of 8% to $168.6M, also reflect Service segment decrease of 1% to $212.4M, Americas segment decrease of 26% to $90.2M.